Namenda - MSN Newsfeeds
- Forbes - All patients were on stable doses of acetylcholinesterase inhibitors, with or without memantine. Patients were randomized to receive tramiprosate (Alzhemed) 100 mg, 150 mg, or placebo twice a day for 18 months. Safety and efficacy assessments were ...
- Senior Journal - All patients were on stable doses of acetylcholinesterase inhibitors, with or without memantine. Patients were randomized to receive tramiprosate (Alzhemed) 100 mg, 150 mg, or placebo twice a day for 18 months. Safety and efficacy ...
- New York Times - The drugs — Aricept by Eisai and Pfizer , Exelon by Novartis , Razadyne by Johnson & Johnson and Namenda by Forest Laboratories — have shown mixed results treating Alzheimer’s symptoms and do nothing to stop the disease’s progress. Dr. Todd Golde ...
- Reuters India - Forest, a mid-sized U.S. drugmaker, is profiting from the strong performance of its Lexapro antidepressant and Namenda Alzheimer's disease treatment. But the drugmaker has been counting on desmoteplase and other experimental drugs to help preserve its ...
- MSN MoneyCentral - Namenda(R) (memantine HCl), an N-methyl D- aspartate (NMDA)-receptor antagonist indicated for the treatment of moderate to severe Alzheimer's disease; Benicar(R)* (olmesartan medoxomil), an angiotensin receptor blocker, and Benicar* HCT(R ...
- MSN MoneyCentral - Namenda(R) (memantine HCl), an N-methyl D-aspartate (NMDA)-receptor antagonist indicated for the treatment of moderate to severe Alzheimer's disease; Benicar(R)* (olmesartan medoxomil), an angiotensin receptor blocker, and Benicar* HCT(R ...
- Inside Bay Area - While these drugs — such as Namenda, Aricept, Reminyl and Excelon — are readily available, they do not replace the care patients need. This responsibility can be difficult, but there are some steps family members can take to prepare for it. ...
- Street.Com - We have taken a fairly aggressive attitude." Forest's sense of urgency is based on the fact that the antidepressant Lexapro provided $2.1 billion, or 61% of revenue, and the Alzheimer's drug Namenda accounted for $660 million, or 19%, for the fiscal ...
- Phramalive.com - ... 8 million from the reimbursement of the direct expenses incurred for services to administer the Phase III clinical trials for XERECEPT in the United States and Canada, and $1.7 million from royalty fees from the commercial sales of Memantine by Merz ...
- Senior Journal - The authors looked at drugs like galantamine (Reminyl), rivastigmine (Exelon), donepezil (Aricept) and memantine (Namenda). But when the authors reviewed the evidence relating to heart-protecting therapy and dementia, they found ...
- Medford Mail Tribune - For people who already have moderate to severe memory loss and thinking problems, physicians may prescribe memantine, a drug that shows promise for slowing late-stage Alzheimer's. Call Bill Kettler at 776-4492, or e-mail them to: bkettler@mailtribune ...
- Motley Fool - There's no cure for Alzheimer's, but Aricept and other such treatments, like Forest Labs ' (NYSE: FRX ) Namenda, delay its progression by allowing for improved cognitive ability. Co-marketed with Pfizer (NYSE: PFE ) , Aricept is currently the only drug ...
- KCPQ 13 FOX - Because of the findings that implicate NDMA reactions, doctors are testing the benefits of the Alzheimer's drug Namenda, which works directly on NMDA receptors. Animal studies suggest it does protect against the death of the cells that have these ...
- HealthCentral.com - Aricept, Exelon, Razadyne and Namenda, but the prospect of having several more options is huge--particularly for families who have exhausted the benefit of the existing meds. Instead of watching their loved one go deeper into dementia and facing the ...
- BusinessWeek - He said generic competition may eventually become an issue for the New York-based company, which needs to bring more products to the market -- though Alzheimer drug Namenda remains a bright spot, he noted. Other peers in the sector garnering "Buy ...
- Channel 4 News - Another drug, Ebixa (memantine), is only to be used in clinical studies for people with moderately severe to severe Alzheimer's disease. On Monday Eisai, the licence holder of Aricept, and Pfizer, its co-promotion partner, announced they had been ...
- Register-Herald - Aricept, Exelon, Reminyl and Namenda are among the brand names of drugs used to treat Alzheimer’s patients. “Studies show that combinations of the drugs work better than using only one drug,” he said. — E-mail: bdavis@register-herald.com ...
- HealthCentral.com - Memantine is currently the only drug approved for treatment of the later stages of Alzheimer’s disease. Newer antipsychotic drugs (aripiprazole, clozapine, olanzapine, quetiapine, risperidone, and ziprasidone) may not be safer than older ...
- Norwich Bulletin - Recently, we have begun to use medications such as Aricept and Namenda that may slow the progression and hopefully improve some of the symptoms. As many as 4.5 million Americans suffer from Alzheimer's disease. This number has doubled since 1980. Many ...
- Norwich Bulletin - As we age, the brain gradually becomes smaller. For Alzheimer's patients, this happens more quickly than in the normal aging process. Recently, we have begun to use medications such as Aricept and Namenda that may slow the progression and hopefully ...
Pages: 1 2 3 4 5 Next
These articles are related to: Namenda Claim, Namenda Lawsuit, Namenda Law Suit, Namenda Law Firm, Namenda Lawyer, Namenda Attorney, Namenda Side Effects Symptoms, Namenda Trial, Namenda Verdict, Namenda News, Namenda Information, Namenda Recall Lawyers, Namenda Warning, Namenda Class Action, Namenda Prescription Drug, Namenda Medication, Namenda Drugs, Memantine Claim, Memantine Lawsuit, Memantine Law Suit, Memantine Law Firm, Memantine Lawyer, Memantine Attorney, Memantine Side Effects Symptoms, Memantine Trial, Memantine Verdict, Memantine News, Memantine Information, Memantine Recall Lawyers, Memantine Warning, Memantine Class Action, Memantine Prescription Drug, Memantine Medication, Memantine Drugs






